×
About 32,285 results

ALLMedicine™ Constipation Center

Research & Reviews  7,108 results

Rectal measurements and their correlation with bowel habits: Evaluation by trans-abdomi...
https://doi.org/10.1111/jpc.16104
Journal of Paediatrics and Child Health; Shapouri S, Matani R et. al.

Jul 3rd, 2022 - Constipation is one of the most common complaints in childhood affecting the quality of life of both children and parents. This study intends to investigate rectal measurements on ultrasound and their relationship with bowel habits. In this cross-...

Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)
https://clinicaltrials.gov/ct2/show/NCT04026113

Jul 1st, 2022 - The objective of LIN-MD-64 is to evaluate the safety and efficacy of 12 weeks of linaclotide therapy (72 μg daily) in comparison with placebo in pediatric participants, 6 to 17 years of age, who fulfill modified Rome III Criteria for Child/Adolesc...

Irritability and Constipation in a 6-month-old Boy.
https://doi.org/10.1542/pir.2022-003087
Pediatrics in Review; Fischer J, Clark R

Jul 1st, 2022 - Irritability and Constipation in a 6-month-old Boy.|2022|Fischer J,Clark R,|

see more →

Guidelines  17 results

AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Sy...
https://doi.org/10.1053/j.gastro.2022.04.016
Gastroenterology Chang L, Sultan S et. al.

Jun 24th, 2022 - Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction associated with significant disease burden. This American Gastroenterological Association guideline is intended to support practitioners in decisions about the use of med...

My Treatment Approach to Multiple System Atrophy.
https://doi.org/10.1016/j.mayocp.2020.10.005
Mayo Clinic Proceedings; Coon EA, Ahlskog JE

Mar 7th, 2021 - Multiple system atrophy (MSA) is a neurodegenerative disorder primarily characterized by autonomic failure plus parkinsonism or cerebellar ataxia. The diagnosis may be challenging and is usually made at a tertiary care center. The long-term manage...

European society of neurogastroenterology and motility guidelines on functional constip...
https://doi.org/10.1111/nmo.13762
Neurogastroenterology and Motility : the Official Journal... Serra J, Pohl D et. al.

Nov 23rd, 2019 - Chronic constipation is a common disorder with a reported prevalence ranging from 3% to 27% in the general population. Several management strategies, including diagnostic tests, empiric treatments, and specific treatments, have been developed. Our...

Medical Management of Opioid-Induced Constipation.
https://doi.org/10.1001/jama.2019.15852
JAMA Rao VL, Micic D et. al.

Nov 5th, 2019 - Medical Management of Opioid-Induced Constipation.|2019|Rao VL,Micic D,Davis AM,|adverse effects,therapeutic use,therapeutic use,therapeutic use,analogs & derivatives,therapeutic use,therapeutic use,drug therapy,therapeutic use,

MASCC recommendations on the management of constipation in patients with advanced cancer.
https://doi.org/10.1007/s00520-019-05016-4
Supportive Care in Cancer : Official Journal of the Multi... Davies A, Leach C et. al.

Aug 10th, 2019 - The Palliative Care Study Group of the Multinational Association for Supportive Care in Cancer formed a subgroup to develop evidence-based recommendations on the management of constipation in patients with advanced cancer. These recommendations we...

see more →

Drugs  2,617 results see all →

Clinicaltrials.gov  1,451 results

Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)
https://clinicaltrials.gov/ct2/show/NCT04026113

Jul 1st, 2022 - The objective of LIN-MD-64 is to evaluate the safety and efficacy of 12 weeks of linaclotide therapy (72 μg daily) in comparison with placebo in pediatric participants, 6 to 17 years of age, who fulfill modified Rome III Criteria for Child/Adolesc...

Administration of a Natural Molecular Complex in Functional Chronic Constipation
https://clinicaltrials.gov/ct2/show/NCT05192317

Jun 30th, 2022 - According to the criteria of Rome IV, 86 patients diagnosed from chronic constipation will be enrolled by up to ten centers. The study includes 2 visits at the site center and 1 by phone call. V-1 (eligibility assessment / screening visit): Collec...

Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 Years
https://clinicaltrials.gov/ct2/show/NCT05404022

Jun 29th, 2022 - BACKGROUND Lung cancer is the third most commonly diagnosed cancer in the UK and most common in Yorkshire. It is also the most common cause of cancer death in UK. People with lung cancer are often older with co-morbidities and frailty resulting in...

Clinical Implementation of a Pictographic Constipation Action Plan for Children With Functional Constipation
https://clinicaltrials.gov/ct2/show/NCT05437523

Jun 29th, 2022 - Bakcground Worldwide, it is estimated that constipation affects 0.7% to 29.6% of children. Constipation accounts for 3% to 10% of general pediatric outpatient visits and up to 25% of visits to pediatric gastroenterologists. Constipation is often a...

Effect of Preoperative Fiber on Postoperative Bowel Function
https://clinicaltrials.gov/ct2/show/NCT04882995

Jun 28th, 2022 - Post-operative constipation or delay in return to bowel function is a common concern among patients undergoing pelvic reconstructive surgery. A retrospective study reviewing all patient-initiated telephone calls in the postoperative period after p...

see more →

News  1,544 results

Irritable Bowel Syndrome Therapy Removed From Market (Again)
https://www.medscape.com/viewarticle/976460

Jun 30th, 2022 - Zelnorm (tegaserod), an oral short-term treatment of irritable bowel syndrome and constipation (IBS-C), is being removed from the US market effective June 30, according to the manufacturer, Alfasigma. The Italian pharmaceutical company said the dr...

Erenumab effective and well -tolerated in chronic migraine
https://www.mdedge.com/migraine-icymi/article/255895/headache-migraine/erenumab-effective-and-well-tolerated-chronic

Jun 29th, 2022 - Key clinical point: Erenumab is effective and well tolerated in patients with chronic migraine who did not respond to previous migraine treatments. Major finding: Overall, 71.

Opioids May Cause More Harm Than Good After Mild to Moderate Surgery
https://www.medscape.com/viewarticle/976379

Jun 29th, 2022 - Opioid prescriptions after minor to moderate surgeries do not reduce pain after patient discharge, according to a new meta-analysis. Researchers also found that patients given opioid prescriptions are at higher risk of adverse events, including vo...

Pharmacologic Treatment of IBS: AGA Clinical Practice Guidelines
https://www.medscape.com/viewarticle/976192

Jun 24th, 2022 - The American Gastroenterological Association has issued new guidelines for the medical treatment of irritable bowel syndrome (IBS). The guidelines, which are separated into one publication for IBS with constipation (IBS-C) and another for IBS with...

AGA Clinical Practice Guidelines: Pharmacologic treatment of IBS
https://www.mdedge.com/internalmedicine/article/255665/gastroenterology/aga-clinical-practice-guidelines-pharmacologic
Will Pass

Jun 22nd, 2022 - The American Gastroenterological Association has issued new guidelines for the medical treatment of irritable bowel syndrome (IBS). The guidelines, which are separated into one publication for IBS with constipation (IBS-C) and another for IBS with.

see more →

Patient Education  177 results see all →